Texas Children’s Cancer Center researchers present at world-renowned neuroblastoma conference
HOUSTON – June 18, 2012 – Dr. Eugene Kim, a pediatric surgeon with Texas Children’s Cancer Center and assistant professor of surgery at Baylor College of Medicine (BCM), and Dr. Jason Shohet, chair of the Neuroblastoma Research Program at Texas Children’s Cancer Center and associate professor in the Section of Hematology-Oncology at BCM, will speak at the Advances in Neuroblastoma Research (ANR) conference about the identification of a novel stem cell population in neuroblastoma.
Kim and Shohet, co-senior authors of the study, use flow cytometry and specific surface markers to isolate a distinct subset of neuroblastoma cells which closely resemble other types of stem cells and are highly tumorigenic in vivo. By identifying this novel cancer stem cell population in neuroblastoma, pediatric oncologists can begin to develop specialized anti-stem cell therapies with the goal of improving outcomes against this deadly and aggressive cancer.
Neuroblastoma is the most common abdominal malignancy in children. Despite modern chemotherapy, surgery and radiation therapies, survival is less than 50 percent for children with high-risk disease. While the reasons behind why tumor recurrence happens in some children remains unclear, cancer stem cells are thought to be responsible for relapse.
“Cancer stem cells are like super cancer cells with the ability to re-create whole tumors from a single cell,” said Kim. “Cancer stem cells, which have been found to be resistant to both chemotherapy and radiation, can differentiate into a variety of related tumor cells.”
The ANR conference – a scientific symposium on neuroblastoma where pre-clinical and clinical research is discussed – brings more than 700 delegates from all over the world together to discuss translational and clinical research in pediatric oncology. The participants represent most of the world’s researchers involved in studying and treating neuroblastoma.
In addition to the study co-authored by Kim and Shohet, Dr. Jed Nuchtern, Chief of the Division of Pediatric Surgery at Texas Children’s Hospital, and a pediatric surgeon with Texas Children’s Cancer Center and Professor of Surgery at BCM, will present the findings of a nationwide study he led that focused on neuroblastoma and the observation of infants with adrenal masses.
The conference is held every two years and the 2012 event will be held in Toronoto from June 18 to 21. Kim, Shohet and Nuchtern will present their studies on June 21, 2012.
About Texas Children's Hospital
Texas Children’s Hospital, a not-for-profit organization, is committed to creating a community of healthy children through excellence in patient care, education and research. Consistently ranked among the top children’s hospitals in the nation, Texas Children’s has recognized Centers of Excellence in multiple pediatric subspecialties including the Cancer and Heart Centers, and operates the largest primary pediatric care network in the country. Texas Children's has completed a $1.5 billion expansion, which includes the Jan and Dan Duncan Neurological Research Institute; Texas Children’s Pavilion for Women, a comprehensive obstetrics/gynecology facility focusing on high-risk births; and Texas Children’s Hospital West Campus, a community hospital in suburban West Houston. For more information on Texas Children's, go to www.texaschildrens.org. Get the latest news from Texas Children’s by visiting the online newsroom and on Twitter at www.twitter.com/texaschildrens.
News Features
-
- May 14, 2013
- 'Off-the-shelf' virus-specific T-cells fight viral infections in stem cell transplant patients
Viral infections present deadly threats to patients who have received donor blood, marrow and cord stem cells transplants and are immune deficient while their transplants begin to work.
-
- April 9, 2013
- BCM major part of new pediatric cancer Dream Team initiative
Baylor College of Medicine is part of a Dream Team of childhood cancer researchers that will focus on melding the fields of genomics and immunotherapy to advance treatment for pediatric cancer.
-
- March 28, 2013
- Wipe Out Kids’ Cancer donates $75,000 to Texas Children’s Cancer Center
The grant will be used to fund a research project on neuroblastoma, an aggressive pediatric cancer that strikes approximately 650 children a year in the U.S., usually before age 5.
-
- March 1, 2013
- Fundraiser supports pediatric cancer in South Texas
Actor Diego Boneta, top right, helped raised $90,000 for the Vannie Cook Children’s Cancer Clinic in South Texas at the 2013 Radiothon.
-
- February 27, 2013
- Hematology-oncology faculty members receive renewed NIH funding to enhance T cell therapy for cancer
Hematology-oncology faculty members from the Center for Cell and Gene Therapy (CAGT) have received a $11.3 million renewal grant from the National Institutes of Health to advance the development of more effective and less toxic targeted T cell therapies for children and adults with cancer.
-
- February 1, 2013
- Grant funds developmental therapeutics program
A five-year, $1.75 million grant from Alex’s Lemonade Stand Foundation was awarded to Texas Children’s Cancer Center to establish the Developmental Therapeutics Center of Excellence.
-
- January 4, 2013
- Houston Radio Host Kevin Kline Completes his 62,000 Step Stair Run
Kevin Kline, Houston morning radio host on The New 93Q, ran 62,000 Stairs at Constellation Field, home of the Sugar Land Skeeters Baseball team in Sugarland, TX.
- December 12, 2012
- Vegetable compound could become ingredient to treating leukemia
A concentrated form of a compound called sulforaphane found in broccoli and other cruciferous vegetables has been shown to reduce the number of acute lymphoblastic leukemia cells in the lab setting, said researchers at Baylor College of Medicine. The findings appear in the current edition of PLOS ONE.
-
- December 11, 2012
- Montblanc and Texas Children’s Cancer Center encourage families to give a gift that counts this holiday season
Montblanc and Texas Children’s Cancer Center have launched a new initiative allowing people across the United States to show their support for children and adolescents fighting cancer by providing an opportunity to purchase a specially designed bracelet to be given to the parent of a pediatric cancer patient this holiday season.
-
- December 6, 2012
- Q&A: Sharon Plon on Baylor College of Medicine's First Year of Clinical Exome Sequencing
As a member of Baylor College of Medicine's Whole Genome Laboratory management committee, Sharon Plon has been a leader in establishing Baylor's clinical exome sequencing diagnostic test, which was launched last November.
This is part one of a two-part interview. Part two will appear in next week's issue.